Clinical Trials
20 trialsNCT03947151 2026-03-31
DEGASTIM
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT00616967 2026-03-05
Carboplatin and Nab-Paclitaxel With or Without Vorinostat in Treating Women With Newly Diagnosed Operable Breast Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase 2 Active not recruiting
NCT00295893 2025-09-25
Combination Chemotherapy With or Without Trastuzumab in Treating Patients With Stage II or Stage III Breast Cancer
City of Hope Medical Center
Phase 2 Active not recruiting
NCT04084730 2025-09-16
Study of 3-Day Partial Breast Radiation Therapy in Women With Breast Cancer
Memorial Sloan Kettering Cancer Center
Phase 2 Recruiting
NCT00909909 2023-08-03
Radiation Therapy in Treating Women With Early Stage Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Active not recruiting
NCT00002934 2023-06-22
Evaluation of Breast Cancer Recurrence Rates Following Surgery in Women With Ductal Carcinoma In Situ
Eastern Cooperative Oncology Group
Phase 2 Terminated
NCT01417286 2023-04-20
Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT01082211 2022-06-21
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Radiation Therapy Oncology Group
Phase 2 Completed
NCT03113825 2021-06-11
Study of AVB-620 in Women With Primary, Nonrecurrent Breast Cancer Undergoing Surgery
Avelas Biosciences, Inc.
Phase 2 Completed
NCT02682693 2021-02-02
GeparX
GBG Forschungs GmbH
Phase 2 Completed
NCT01891357 2019-09-17
Phase II Trial to Validate Markers for a Response Evaluation of a Combined Therapy in Patients With HER2+ Breast Cancer
West German Study Group
Phase 2 Terminated
NCT00096343 2018-12-04
Paclitaxel and Carboplatin in Treating Women Who Are Undergoing Surgery for Newly Diagnosed, Locally Advanced Breast Cancer
University of Alabama at Birmingham
Phase 2 Completed
NCT00088972 2018-08-10
S0300, Celecoxib in Preventing Breast Cancer in Premenopausal Women
SWOG Cancer Research Network
Phase 2 Terminated
NCT00870415 2017-08-21
Breast-Conserving Surgery Techniques in Treating Women With Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Completed
NCT00723294 2017-08-14
Cryoablation Therapy in Treating Patients With Invasive Ductal Breast Cancer
Alliance for Clinical Trials in Oncology
Phase 2 Unknown
NCT00182793 2017-02-23
Combination Chemotherapy With or Without Trastuzumab Followed By an Autologous Stem Cell Transplant and Radiation Therapy in Treating Patients With Stage III or Stage IV Breast Cancer
City of Hope Medical Center
Phase 2 Completed
NCT02199418 2017-01-25
SHPD001
RenJi Hospital
Phase 2 Completed
NCT00154388 2016-11-18
Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases
Novartis
Phase 2 Completed
NCT00960336 2014-10-29
Doxorubicin Hydrochloride Liposome as First-Line Therapy in Treating Older Women With Metastatic Breast Cancer
ARCAGY/ GINECO GROUP
Phase 2 Completed
NCT01100489 2011-12-08
Breast-Conserving Surgery Followed by Radiation Therapy With MRI-Detected Stage I or Stage II Breast Cancer
Case Comprehensive Cancer Center
Phase 2 Withdrawn